3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
5
Unknown
1
Terminated
1
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Eunuchism
2
Sarcopenia
1
Prostatic Neoplasms
1
Osteoporosis
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Neoplasms
1
Metabolic Syndrome
1
Metabolic Diseases
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Arthralgia
1
Interventions
Exercise
18
Drug Therapy
17
pembrolizumab
12
Capecitabine
11
Blood Specimen Collection
11
Surveys and Questionnaires
10
Radiotherapy
10
Dexamethasone
9
Paclitaxel
8
Standard of Care
7
Oxaliplatin
7
Nivolumab
7
Fluorouracil
7
Erlotinib Hydrochloride
7
apatinib
6
Interviews as Topic
6
Gemcitabine
6
Cisplatin
6
Therapeutics
5
Neoadjuvant Therapy
5
Mindfulness-Based Cognitive Therapy
5
Metformin
5
Injections
5
Everolimus
5
Docetaxel
5
Cyclophosphamide
5
Control Groups
5
Bevacizumab
5
sintilimab
4
atezolizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasms
×
Testosterone
×
Clear all
NCT00497458
2009-04-09
ART2
Havah Therapeutics Pty Ltd
Phase 2
Unknown
90 enrolled